| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |